Search hospitals > Wisconsin > Madison
University of Wisconsin - Carbone Cancer Center
Claim this profileMadison, Wisconsin 53792
Global Leader in Cancer
Global Leader in Tumors
Conducts research for Breast Cancer
Conducts research for Lymphoma
Conducts research for Brain Tumor
773 reported clinical trials
64 medical researchers
Summary
University of Wisconsin - Carbone Cancer Center is a medical facility located in Madison, Wisconsin. This center is recognized for care of Cancer, Tumors, Breast Cancer, Lymphoma, Brain Tumor and other specialties. University of Wisconsin - Carbone Cancer Center is involved with conducting 773 clinical trials across 570 conditions. There are 64 research doctors associated with this hospital, such as Kenneth B. De Santes, Nataliya V. Uboha, Kari B. Wisinski, and Ticiana A. Leal.Area of expertise
1Cancer
Global LeaderStage IV
Stage III
Stage II
2Tumors
Global LeaderStage IV
Stage III
Stage I
Top PIs
Kenneth B. De SantesUniversity of Wisconsin Carbone Cancer Center7 years of reported clinical research
Expert in Tumors
Expert in Brain Tumor
57 reported clinical trials
104 drugs studied
Nataliya V. UbohaUniversity of Wisconsin Carbone Cancer Center5 years of reported clinical research
Studies Tumors
Studies Cancer
20 reported clinical trials
54 drugs studied
Kari B. WisinskiUniversity of Wisconsin Carbone Cancer Center6 years of reported clinical research
Expert in Breast Cancer
Studies Cancer
18 reported clinical trials
49 drugs studied
Ticiana A. LealUniversity of Wisconsin Hospital and Clinics4 years of reported clinical research
Expert in Non-Small Cell Lung Cancer
Expert in Lung Cancer
16 reported clinical trials
23 drugs studied
Clinical Trials running at University of Wisconsin - Carbone Cancer Center
Breast Cancer
Lung Cancer
Cancer
Non-Small Cell Lung Cancer
Ovarian Cancer
Fallopian Tube Cancer
Squamous Cell Carcinoma
Recurrence
Gastric Cancer
Ovarian Tumors
Triple Drug Combo
for Advanced Breast Cancer
The purpose of this study is to evaluate the safety and efficacy of the three-drug combination of tucatinib, trastuzumab, and eribulin in patients with de novo and recurrent unresectable metastatic HER-2/neu positive breast cancer as assessed by ORR, PFS and OS after prior treatment with a taxane, trastuzumab, and T-DM1.
Recruiting3 awards Phase 217 criteria
FES Imaging + Tamoxifen
for Breast Cancer
Despite broad advancements in endocrine therapy for ERα+ breast cancer, resistance ultimately develops. A common driver of resistance are known ESR1 mutations that lead to constitutively active receptor signaling and transcriptional regulation that is always "turned on" despite the absence of estrogen. Patients with ESR1 mutations are expected to have decreased binding affinity for tamoxifen and thus may be underdosed on standard therapy. \[18F\]-fluoroestradiol Positron Emission Tomography/Computed tomography (FES-PET/CT) imaging is a novel functional imaging technique that can non-invasively measure ERα expression and inhibition in metastatic ERα+ breast cancer. The proposed a pilot study uses FES-PET/CT imaging to measure ERα blockade to determine the optimal dose of tamoxifen in patients with ESR1 mutations.
Recruiting3 awards Phase < 113 criteria
Paclitaxel
for Breast Cancer
The hypothesis of this study is that paclitaxel levels increase chromosomal instability (CIN) in tumors and this is lethal to tumors that have pre-existing CIN. Treatment will be administered on an outpatient basis. Paclitaxel will be initiated as standard infusions on days 1, 8, and 15 of a 21-day cycle. Participants will continue with paclitaxel for cycles 2-4 prior to surgery.
Recruiting3 awards Phase 46 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at University of Wisconsin - Carbone Cancer Center?
University of Wisconsin - Carbone Cancer Center is a medical facility located in Madison, Wisconsin. This center is recognized for care of Cancer, Tumors, Breast Cancer, Lymphoma, Brain Tumor and other specialties. University of Wisconsin - Carbone Cancer Center is involved with conducting 773 clinical trials across 570 conditions. There are 64 research doctors associated with this hospital, such as Kenneth B. De Santes, Nataliya V. Uboha, Kari B. Wisinski, and Ticiana A. Leal.
Where is University of Wisconsin - Carbone Cancer Center located?
**Carbone Cancer Center Location and Directions:**
- **Address:** 600 Highland Ave, Madison, WI 53792.
- **Directions:** Upon entering, follow the Main Street stone path north to the K module. Use the double set of elevators to the first level, cross the lobby, and proceed down the hallway to the Wisconsin Institutes for Medical Research elevators. Take these elevators to the B level, turn right to enter Radiation Oncology, and check in at the Radiation reception area.
Who should I call to ask about financial aid or insurance network?
For financial assistance and insurance inquiries at the University of Wisconsin Carbone Cancer Center:
- Contact the UW Health Billing and Insurance department at (877) 278-6437 (Wisconsin) or (800) 305-8010 (Illinois) for financial counseling, insurance coverage understanding, and payment plans.
- Reach out to Elevate Patient Financial Solutions at (608) 265-1705 for governmental financial program assistance.
- For specific cancer center financial assistance, contact (608) 265-1700 or email cancercenter@mailplus.wisc.edu.
What insurance does University of Wisconsin - Carbone Cancer Center accept?
The University of Wisconsin - Carbone Cancer Center accepts a variety of insurance plans, including Quartz. Patients should contact the hospital directly or visit their website for a detailed list of accepted insurance plans. It's important for patients to check if their insurance plan requires a referral from a primary care physician before seeing a UW Health physician.
What awards or recognition has University of Wisconsin - Carbone Cancer Center received?
The University of Wisconsin Carbone Cancer Center is renowned for its innovative cancer research and quality patient care, earning recognition across the Midwest and nationally. It specializes in a wide range of research areas including genetic and epigenetic mechanisms, cancer prevention and control, developmental therapeutics, human cancer virology, imaging and radiation sciences, and tumor microenvironment. Committed to defeating cancer, the center focuses on the rapid application of groundbreaking research, prevention, and treatment strategies.